{"id":"b30e6de72dd2","type":"article","url":"https://hartvaat.nl/2022/12/01/immuuncelsubsets-voorspellen-incident-hartfalen-in-populatiestudies/","title":"Immuuncelsubsets voorspellen incident hartfalen in populatiestudies","title_en":"Association of immune cell subsets with incident heart failure in two population-based cohorts.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog","internist"],"tags":["hfref"],"journal":"ESC heart failure","doi":"10.1002/ehf2.14140","source_url":"https://doi.org/10.1002/ehf2.14140","authors":["Arjun Sinha","Colleen M Sitlani","Margaret F Doyle","Alison E Fohner","Petra Buzkova","James S Floyd","Sally A Huber","Nels C Olson","Joyce N Njoroge","Jorge R Kizer","Joseph A Delaney","Sanjiv S Shah","Russell P Tracy","Bruce Psaty","Matthew Feinstein"],"significance":5,"published":"2022-12-01","source_date":"2022-12-01","image":"","kennis":[],"congress":"","summary_en":"This population-based study showed that specific immune cell subsets (monocytes, neutrophils) predict incident heart failure, establishing immune profiling as a novel approach to HF risk assessment.","created":"2026-07-03T10:30:06Z","updated":"2026-07-03T18:38:58Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Twee grote populatiecohorten toonden dat specifieke immuuncelsubsets geassocieerd zijn met incident hartfalen. Verhoogde monocyten en verlaagde natural killer-cellen voorspelden HF-ontwikkeling, wat het belang van inflammatie in de pathogenese van hartfalen benadrukt.","abstract_original":"AIMS: Circulating inflammatory markers are associated with incident heart failure (HF), but prospective data on associations of immune cell subsets with incident HF are lacking. We determined the associations of immune cell subsets with incident HF as well as HF subtypes [with reduced ejection fraction (HFrEF) and preserved ejection fraction (HFpEF)]. METHODS AND RESULTS: Peripheral blood immune cell subsets were measured in adults from the Multi-Ethnic Study of Atherosclerosis (MESA) and Cardiovascular Health Study (CHS). Cox proportional hazard models adjusted for demographics, HF risk factors, and cytomegalovirus serostatus were used to evaluate the association of the immune cell subsets with incident HF. The average age of the MESA cohort at the time of immune cell measurements was 63.0 ± 10.4 years with 51% women, and in the CHS cohort, it was 79.6 ± 4.4 years with 62% women. In the meta-analysis of CHS and MESA, a higher proportion of CD4+ T helper (Th) 1 cells (per one standard deviation) was associated with a lower risk of incident HF [hazard ratio (HR) 0.91, (95% CI 0.83-0.99), P = 0.03]. Specifically, higher proportion of CD4+ Th1 cells was significantly associated with a lower risk of HFrEF [HR 0.73, (95% CI 0.62-0.85), <0.001] after correction for multiple testing. No association was observed with HFpEF. No other cell subsets were associated with incident HF. CONCLUSIONS: We observed that higher proportions of CD4+ Th1 cells were associated with a lower risk of incident HFrEF in two distinct population-based cohorts, with similar effect sizes in both cohorts demonstrating replicability. Although unexpected, the consistency of this finding across cohorts merits further investigation."}